Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

    Recruiting

    2 1 1 1
    France Germany
  • Study of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

    Recruiting

    4 1 1 1
    France
  • Study on Golcadomide and Valemetostat Tosylate for Patients with Relapsed or Refractory Non-Hodgkin Lymphomas

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark France Italy Spain
  • Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

    Recruiting

    2 1 1 1
    Investigated drugs:
    Czechia France Italy Poland Spain
  • Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +2
  • Study on the Effectiveness of Etoposide Phosphate, Carboplatin, Methotrexate, Rituximab, and Cyclophosphamide in Patients with Primary Central Nervous System Lymphoma

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Finland
  • Study on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Germany Italy
  • Study on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma

    Not recruiting

    1 1 1 1
    France
  • Study on the Safety and Effectiveness of Berubicin for Patients with Central Nervous System Lymphomas

    Not recruiting

    1 1 1
    Investigated drugs:
    Poland
  • Study on Methotrexate, Tafasitamab, Lenalidomide, and Rituximab for Patients with Primary Central Nervous System Lymphoma Not Eligible for Stem Cell Transplant

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Germany